Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

559 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia.
Dam M, Centanni M, Friberg LE, Centanni D, Karlsson MO, Stensig Lynggaard L, Johannsdottir IM, Wik HS, Malmros J, Vaitkeviciene GE, Griskevicius L, Hallböök H, Jónsson ÓG, Overgaard U, Schmiegelow K, Hansen SN, Heyman M, Albertsen BK. Dam M, et al. Among authors: schmiegelow k. Leukemia. 2024 Apr;38(4):712-719. doi: 10.1038/s41375-024-02153-6. Epub 2024 Jan 29. Leukemia. 2024. PMID: 38287133 Free PMC article.
Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO).
Gustafsson G, Schmiegelow K, Forestier E, Clausen N, Glomstein A, Jonmundsson G, Mellander L, Mäkipernaa A, Nygaard R, Saarinen-Pihkala UM. Gustafsson G, et al. Among authors: schmiegelow k. Leukemia. 2000 Dec;14(12):2267-75. doi: 10.1038/sj.leu.2401961. Leukemia. 2000. PMID: 11187918
Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome.
Nyvold C, Madsen HO, Ryder LP, Seyfarth J, Svejgaard A, Clausen N, Wesenberg F, Jonsson OG, Forestier E, Schmiegelow K; Nordic Society for Pediatric Hematology and Oncology. Nyvold C, et al. Among authors: schmiegelow k. Blood. 2002 Feb 15;99(4):1253-8. doi: 10.1182/blood.v99.4.1253. Blood. 2002. PMID: 11830473 Free article.
Comparison of intramuscular therapy with Erwinia asparaginase and asparaginase Medac: pharmacokinetics, pharmacodynamics, formation of antibodies and influence on the coagulation system.
Albertsen BK, Schrøder H, Ingerslev J, Jakobsen P, Avramis VI, Müller HJ, Carlsen NT, Schmiegelow K. Albertsen BK, et al. Among authors: schmiegelow k. Br J Haematol. 2001 Dec;115(4):983-90. doi: 10.1046/j.1365-2141.2001.03148.x. Br J Haematol. 2001. PMID: 11843837 Free article.
559 results